文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

肠道微生物群在癌症抑制中的作用。

Role of gut microbiome in suppression of cancers.

作者信息

Xu Yao, Gao Zhaoyu, Liu Jiaying, Yang Qianqian, Xu Shunjiang

机构信息

Central Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang, P. R. China.

Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, P. R. China.

出版信息

Gut Microbes. 2025 Dec;17(1):2495183. doi: 10.1080/19490976.2025.2495183. Epub 2025 Apr 20.


DOI:10.1080/19490976.2025.2495183
PMID:40254597
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12013426/
Abstract

The pathogenesis of cancer is closely related to the disruption of homeostasis in the human body. The gut microbiome plays crucial roles in maintaining the homeostasis of its host throughout lifespan. In recent years, a large number of studies have shown that dysbiosis of the gut microbiome is involved in the entire process of cancer initiation, development, and prognosis by influencing the host immune system and metabolism. Some specific intestinal bacteria promote the occurrence and development of cancers under certain conditions. Conversely, some other specific intestinal bacteria suppress the oncogenesis and progression of cancers, including inhibiting the occurrence of cancers, delaying the progression of cancers and boosting the therapeutic effect on cancers. The promoting effects of the gut microbiome on cancers have been comprehensively discussed in the previous review. This article will review the latest advances in the roles and mechanisms of gut microbiome in cancer suppression, providing a new perspective for developing strategies of cancer prevention and treatment.

摘要

癌症的发病机制与人体体内稳态的破坏密切相关。肠道微生物群在宿主的整个生命周期中对维持其体内稳态起着至关重要的作用。近年来,大量研究表明,肠道微生物群的失调通过影响宿主免疫系统和新陈代谢,参与了癌症发生、发展和预后的全过程。某些特定的肠道细菌在特定条件下会促进癌症的发生和发展。相反,其他一些特定的肠道细菌则会抑制癌症的发生和进展,包括抑制癌症的发生、延缓癌症的进展以及增强对癌症的治疗效果。肠道微生物群对癌症的促进作用已在前一篇综述中进行了全面讨论。本文将综述肠道微生物群在癌症抑制中的作用及机制的最新进展,为制定癌症预防和治疗策略提供新的视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4db/12013426/ad63f986c540/KGMI_A_2495183_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4db/12013426/ebc1c00de251/KGMI_A_2495183_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4db/12013426/4c2dc1ae23c9/KGMI_A_2495183_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4db/12013426/ad63f986c540/KGMI_A_2495183_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4db/12013426/ebc1c00de251/KGMI_A_2495183_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4db/12013426/4c2dc1ae23c9/KGMI_A_2495183_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4db/12013426/ad63f986c540/KGMI_A_2495183_F0003_OC.jpg

相似文献

[1]
Role of gut microbiome in suppression of cancers.

Gut Microbes. 2025-12

[2]
The Microbiome Matters: Its Impact on Cancer Development and Therapeutic Responses.

J Microbiol. 2024-3

[3]
Gut microbiome in multiple sclerosis: The players involved and the roles they play.

Gut Microbes. 2017-8-3

[4]
Dysbiosis of the Gut Microbiome is associated with Tumor Biomarkers in Lung Cancer.

Int J Biol Sci. 2019-9-7

[5]
Effects of gut microbiome and obesity on the development, progression and prevention of cancer (Review).

Int J Oncol. 2024-1

[6]
Distinct gut microbiomes in Thai patients with colorectal polyps.

World J Gastroenterol. 2024-7-21

[7]
Targeting the gut and tumor microbiome in cancer treatment resistance.

Am J Physiol Cell Physiol. 2024-12-1

[8]
Interkingdom signaling between gastrointestinal hormones and the gut microbiome.

Gut Microbes. 2025-12

[9]
Helminth-Induced Human Gastrointestinal Dysbiosis: a Systematic Review and Meta-Analysis Reveals Insights into Altered Taxon Diversity and Microbial Gradient Collapse.

mBio. 2021-12-21

[10]
The Role of the Gut Microbiome on Chronic Kidney Disease.

Adv Appl Microbiol. 2016-7-18

引用本文的文献

[1]
Apoptosis-Inducing Effects of DS0709 in Colorectal Cancer.

J Microbiol Biotechnol. 2025-8-15

本文引用的文献

[1]
Big lessons from the little in hepatocellular carcinoma.

Front Immunol. 2025-2-14

[2]
Natural Enzyme-Loaded Polymeric Stealth Coating-Armed Engineered Probiotics by Disrupting Tumor Lactate Homeostasis to Synergistic Metabolism-Immuno-Enzyme Dynamic Therapy.

Adv Sci (Weinh). 2025-4

[3]
Crosstalk between gut microbiotas and fatty acid metabolism in colorectal cancer.

Cell Death Discov. 2025-2-26

[4]
Intestinal Probiotic Lysate Modified Bifunctional Nanoparticle for Efficient Colon Cancer Immunotherapy.

Pharmaceutics. 2025-1-21

[5]
Upregulation of . in gut microbiota as a novel mechanism for environmental eustress-induced anti-pancreatic cancer effects.

Gut Microbes. 2025-12

[6]
Targeting the Adenosine-Mediated Metabolic Immune Checkpoint with Engineered Probiotic for Enhanced Chemo-Immunotherapy.

Adv Sci (Weinh). 2025-4

[7]
Probiotics: A New Approach for the Prevention and Treatment of Cervical Cancer.

Probiotics Antimicrob Proteins. 2025-2-14

[8]
Dynamic changes in the gut microbiota play a critical role in age-associated cognitive dysfunction via SCFAs and LPS synthesis metabolic pathways during brain aging.

Int J Biol Macromol. 2025-4

[9]
facilitates tumor-derived CCL5 to recruit dendritic cell and suppress colorectal tumorigenesis.

Gut Microbes. 2025-12

[10]
Butyrate-producing suppresses natural killer/T-cell lymphoma by dampening the JAK-STAT pathway.

Gut. 2025-3-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索